# Corneal Collagen Cross-linking for Progressive Keratoconus

> **NCT00647699** · PHASE3 · COMPLETED · sponsor: **Glaukos Corporation** · enrollment: 147 (actual)

## Conditions studied

- Progressive Keratoconus

## Interventions

- **DRUG:** riboflavin ophthalmic solution
- **DEVICE:** UVA Irradiation

## Key facts

- **NCT ID:** NCT00647699
- **Lead sponsor:** Glaukos Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 147 (ACTUAL)
- **Last updated:** 2021-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00647699

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00647699, "Corneal Collagen Cross-linking for Progressive Keratoconus". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00647699. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*